Back to Market Feed

Product Information

STIOLTO RESPIMAT INHALER (60) is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $115.7913 per GM under NDC 00597015561. Its NADAC has been published 390 times since Oct 21, 2015.

FDA first approved this application on May 21, 2015.

STIOLTO RESPIMAT INHALER (60)

tiotropium bromide and olodaterol
$115.7913per GM

Strength

2.736; 3.124 ug/1; ug/1

NDC

00597015561

Classification

Brand

Dosage Form

SPRAY, METERED

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA206756

FDA Approved

5/21/2015

On Market Since

5/21/2015

Pharmacological Classes

Adrenergic beta2-Agonists
Anticholinergic
Cholinergic Antagonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for STIOLTO RESPIMAT INHALER (60) has been published 390 times since Oct 21, 2015, and over the history we have for it it has risen 50.8%. The table below summarizes its recorded NADAC range and movement.

Current price$115.7913 per GM
All-time high$116.1168 (Jun 12, 2024)
All-time low$76.2526 (Nov 18, 2015)
52-week high$115.8759
52-week low$115.7913
Median price$109.3869
Average price$101.1754
Largest weekly change+24.0% (Jan 19, 2022)
Weeks tracked390
Tracking sinceOct 21, 2015

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.0%

3Y

+2.8%

5Y

+31.2%

All

+50.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tiotropium bromide and olodaterol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

CUVPOSA 1 MG/5 ML SOLUTION
Brand
00259050116•Merz Pharmaceuticals, LLC
$1.0080
per ML
ADVAIR 100-50 DISKUS
Brand
00173069500•GlaxoSmithKline LLC
$2.4861
per EA
VENTOLIN HFA 90 MCG INHALER
Brand
00173068224•GlaxoSmithKline LLC
$2.7195
per GM
LOMOTIL 2.5-0.025 MG TABLET
Brand
00025006131•Pfizer Inc.
$3.0028
per EA
VENTOLIN HFA 90 MCG INHALER
Brand
00173068220•GlaxoSmithKline LLC
$3.0351
per GM
ADVAIR 250-50 DISKUS
Brand
00173069604•GlaxoSmithKline LLC
$3.1083
per EA
ADVAIR 250-50 DISKUS
Brand
00173069600•GlaxoSmithKline LLC
$3.1226
per EA
ADVAIR 500-50 DISKUS
Brand
00173069700•GlaxoSmithKline LLC
$4.2272
per EA
XOPENEX HFA 45 MCG INHALER
Brand
27437005601•Lupin Pharmaceuticals Inc.
$4.9891
per GM
BREO ELLIPTA 200-25 MCG INHALR
Brand
00173088214•GlaxoSmithKline LLC
$5.3573
per EA

Frequently asked questions

What is the NADAC price of STIOLTO RESPIMAT INHALER (60)?

The current National Average Drug Acquisition Cost (NADAC) for STIOLTO RESPIMAT INHALER (60), manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $115.7913 per GM (NDC 00597015561), effective Aug 19, 2026.

How has the price of STIOLTO RESPIMAT INHALER (60) changed over time?

Over the history we have for it, the NADAC for STIOLTO RESPIMAT INHALER (60) has risen 50.8%. It has been tracked across 390 weekly CMS publications since Oct 21, 2015.

What are the highest and lowest recorded NADAC prices for STIOLTO RESPIMAT INHALER (60)?

Since Oct 21, 2015, the NADAC for STIOLTO RESPIMAT INHALER (60) has ranged from a low of $76.2526 (Nov 18, 2015) to a high of $116.1168 (Jun 12, 2024), with a median of $109.3869 per GM.

Are there cheaper alternatives to STIOLTO RESPIMAT INHALER (60)?

No other NADAC-published product currently shares the active ingredient and strength of STIOLTO RESPIMAT INHALER (60) in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures STIOLTO RESPIMAT INHALER (60)?

STIOLTO RESPIMAT INHALER (60) (NDC 00597015561) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.